DarioHealth Corp. (DRIO)

Market Cap	16.01M
Revenue (ttm)	27.15M
Net Income (ttm)	-35.72M
Shares Out	2.40M
EPS (ttm)	-13.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	57,506
Open	7.05
Previous Close	7.11
Day's Range	6.58 - 7.85
52-Week Range	6.60 - 31.00
Beta	1.11
Analysts	Strong Buy
Price Target	50.00 (+649.63%)
Earnings Date	Nov 6, 2025

About DRIO

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral heal...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2011
• Employees: 202
• Stock Exchange: NASDAQ
• Ticker Symbol: DRIO
• Website: https://www.dariohealth.com

Financial Performance

In 2024, DarioHealth's revenue was $27.04 million, an increase of 32.86% compared to the previous year's $20.35 million. Losses were -$30.09 million, -45.15% less than in 2023.

Analyst Summary

According to 2 analysts, the average rating for DRIO stock is "Strong Buy." The 12-month stock price target is $50.0, which is an increase of 649.63% from the latest price.

Price Target

$50.0

(649.63% upside)

Analyst Consensus: Strong Buy